Publication:
Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

dc.contributor.authorsKisacik, Bunyamin; Pamuk, Omer; Onat, Ahmet Mesut; Erer, B.; Hatemi, Gulen; Ozguler, Yesim; Pehlivan, Yavuz; Kilic, Levent; Ertenli, Ihsan; Can, Meryem; Direskeneli, Haner; Keser, Gokhan; Oksel, Fahrettin; Dalkilic, Ediz; Yilmaz, Sedat; Pay, Salih; Balkarli, Ayse; Cobankara, Veli; Cetin, Gozde Yildirim; Sayarlioglu, Mehmet; Cefle, Ayse; Yazici, Ayten; Avci, Ali Berkant; Terzioglu, Ender; Ozbek, Suleyman; Akar, Servet; Gul, Ahmet
dc.date.accessioned2022-03-10T17:52:59Z
dc.date.accessioned2026-01-10T17:01:00Z
dc.date.available2022-03-10T17:52:59Z
dc.date.issued2014
dc.identifier.doidoiWOS:000344384904305
dc.identifier.eissn2326-5205
dc.identifier.issn2326-5191
dc.identifier.urihttps://hdl.handle.net/11424/221647
dc.identifier.wosWOS:000344384904305
dc.language.isoeng
dc.publisherWILEY-BLACKWELL
dc.relation.ispartofARTHRITIS & RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleTuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS943
oaire.citation.startPageS943
oaire.citation.titleARTHRITIS & RHEUMATOLOGY
oaire.citation.volume66

Files